| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/21/2004 | US6794546 Reaction of corresponding oh, sh or nh compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds |
| 09/21/2004 | US6794542 Method for the preparation of enantiomerically enriched compounds |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794517 Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients |
| 09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/21/2004 | CA2200316C Imidazole derivative |
| 09/21/2004 | CA2114017C Amide tetrazole acat inhibitors |
| 09/21/2004 | CA2035238C Process for making high solids fabric softeners using low amounts of solvents and eliminating side reactions |
| 09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
| 09/16/2004 | WO2004078908A2 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | WO2004078345A1 Method for producing bisphenol catalysts and bisphenols |
| 09/16/2004 | WO2004078163A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004078161A1 Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | US20040181075 Process of making chalcone derivatives |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180863 Novel, nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/16/2004 | CA2518020A1 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | CA2514733A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/15/2004 | EP1457205A1 Angiogenesis inhibitor |
| 09/15/2004 | EP1456173A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1456151A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 09/15/2004 | EP1194227B1 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
| 09/15/2004 | EP1000932B1 Aromatic ring derivatives |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic |
| 09/15/2004 | EP0693072B9 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529692A N-arylphenylacetamide derivatives and medicinal compositions containing same |
| 09/15/2004 | CN1529684A Use of composition of ionic nature as substitute reagent, composition constituting fluorination reagent and using method thereof |
| 09/15/2004 | CN1528749A Allantoin synthesizing process |
| 09/15/2004 | CN1166652C Preparation method of carbonyl aplpha-substitution nitrogenous compound |
| 09/15/2004 | CN1166641C New cycloheplene compound, its preparation method and medicine composition containing same |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/14/2004 | US6790996 Hydrogenating nitriles in the presence of a supported cobalt containing catalyst to form primary amines |
| 09/14/2004 | US6790953 Ether compounds |
| 09/10/2004 | WO2004076434A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076433A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2004009034A3 Thiomolybdate analogues and uses thereof |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | CA2517391A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176372 Pin1-modulating compounds and methods of use thereof |
| 09/09/2004 | US20040176333 2-Mercaptopropionamide derivatives; |
| 09/09/2004 | DE10308907A1 Ethynylderivate Ethynylderivate |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP1454627A1 Alpha-Keto carbonyl calpain inhibitors |
| 09/08/2004 | EP1453838A2 Production of ionic liquids |
| 09/08/2004 | EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents |
| 09/08/2004 | EP1453811A2 Peroxisome proliferator activated receptor agonists |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | EP0944581A4 Process of preparing substituted acrylamides |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 09/08/2004 | CN1527700A Compaction process for manufacture of sodium phenytoin dosage form |
| 09/08/2004 | CN1526703A Prepn of Nim-tribenzyl histidine |
| 09/07/2004 | US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787522 Antibacterial agents |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above |
| 09/02/2004 | WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids |
| 09/02/2004 | WO2004074238A1 Phenethylamino sulfamic acids |
| 09/02/2004 | WO2004073709A1 Antimicrobial agents |
| 09/02/2004 | WO2004050635A3 Imidazol derivatives having affinity for alpha 2 receptors activity |
| 09/02/2004 | WO2003101954A3 Nf-kb inhibitors and uses thereof |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171844 Dihydro-2H-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 09/02/2004 | US20040171781 From a sulfonate compound containing unsaturated ester group; membrane |
| 09/02/2004 | US20040171663 Neuropathy, nephropathy, ophthalmopathy, arteriosclerosis; long lasting; single, low level daily dosage |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 09/02/2004 | US20040170890 novel 2,2,2-trifluoro-N-(trifluoromethanesulfonyl) acetamide*tetraethyl ammonium salt |
| 09/02/2004 | US20040168263 As stable as oxidation dyes toward light and also resistant to bad weather, washing and perspiration, and which, in addition, are sufficiently stable in presence of oxidizing and reducing agents to be able to simultaneously obtain lightening |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1451207A2 Labeling reagent and methods of use |
| 09/01/2004 | EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 09/01/2004 | EP1450795A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease |
| 09/01/2004 | EP1060165B1 Method for preparing an n-substituted heterocyclic derivative using a phase-transfer catalyst |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |